{"ageusia": 3.17, "anosmia": 17.35, "arthritis": 2.13, "asthma": 15.82, "asthmatic crisis": 18.17, "cataract": 3.97, "chronic obstructive pulmonary disease": 5.21, "condition aggravated": 2.42, "cough": 3.06, "drug hypersensitivity": 2.6, "dyspnoea": 2.65, "dyspnoea exertional": 7.55, "eczema": 7.33, "epistaxis": 13.76, "full blood count abnormal": 51.98, "gastrooesophageal reflux disease": 4.46, "glaucoma": 10.39, "intraocular pressure increased": 11.83, "loss of personal independence in daily activities": 10.68, "macular degeneration": 46.88, "nasal congestion": 15.66, "nasal discomfort": 28.94, "nasal dryness": 25.27, "nasal obstruction": 65.08, "nasal polyps": 115.66, "nsaid exacerbated respiratory disease": 1418.27, "obstructive airways disorder": 40.64, "oral candidiasis": 10.07, "paraesthesia oral": 2.55, "proctitis": 40.6, "product complaint": 12.8, "product prescribing issue": 17.69, "product use in unapproved indication": 2.05, "productive cough": 7.22, "respiratory tract infection": 6.93, "rhinalgia": 52.3, "rhinitis": 5.45, "rhinitis allergic": 17.16, "rhinorrhoea": 8.08, "secretion discharge": 37.05, "sinusitis": 8.86, "sleep apnoea syndrome": 16.03, "sleep disorder due to a general medical condition": 97.66, "sneezing": 5.99, "sputum discoloured": 26.11, "swelling face": 2.1, "therapeutic product effect incomplete": 25.08, "throat clearing": 124.91, "throat irritation": 3.97, "visual acuity reduced": 2.7, "visual impairment": 2.05, "wheezing": 17.01}